Keros Therapeutics, Inc. - common stock financial statements
Annual and standalone quarterly facts filed by the company with the SEC. Monetary values are shown in USD millions; per-share values use USD.
Filed statements
| USD; millions except EPS | Jun 2026Filed 03/08/2026 | Mar 2026Filed 03/08/2026 | Sep 2025Filed 05/11/2025 | Jun 2025Filed 03/08/2026 | Mar 2025Filed 03/08/2026 | Sep 2024Filed 05/11/2025 | Jun 2024Filed 05/11/2025 | Mar 2024Filed 05/11/2025 |
|---|---|---|---|---|---|---|---|---|
| $0 | $0.4 | $14 | $18 | $211 | $0.4 | $0 | $0.1 | |
| −$29 | −$24 | −$7.3 | −$31 | $148 | −$53 | −$45 | −$43 | |
| −$1.45 | −$1.21 | −$0.18 | −$0.76 | $3.62 | −$1.41 | −$1.25 | −$1.21 | |
| 20 | 20 | 41 | 41 | 41 | 38 | 36 | 36 |
Trend